In 2023, thrips resistance and poor insecticide efficacy became a headache for many growers.

Due to the rapid reproduction of thrips, serious generational alternation, and the single use of pesticides by farmers, the resistance of thrips in many areas has continued to increase.

In response to the problem of thrips resistance, SixF staffs have not stopped the pace of research and development and upgrading.

The SixF R&D team overcame difficulties and upgraded Spinosad 5%+Emamectin benzoate 1.8% SC, and began conducting efficacy trials in multiple regions in October 2023.

The new formula has stable efficacy and is significantly effective against thrips, with significant improvements in both rapidity and duration of effectiveness.

Continuously upgrading the formula is the scientific research mission and ultimate pursuit of quality of the SixF R&D team. As long as the pest resistance continues to increase, there is no limit to improving the efficacy.

I believe that in 2024, Spinosad 5%+Emamectin benzoate 1.8% SC will better assist in the prevention and control of thrips and achieve better insecticide results. Let us witness it together!